As of 2025-11-24, the Intrinsic Value of Cross Country Healthcare Inc (CCRN) is 36.00 USD. This CCRN valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 11.21 USD, the upside of Cross Country Healthcare Inc is 221.10%.
The range of the Intrinsic Value is 27.43 - 55.19 USD
Based on its market price of 11.21 USD and our intrinsic valuation, Cross Country Healthcare Inc (CCRN) is undervalued by 221.10%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 27.43 - 55.19 | 36.00 | 221.1% |
| DCF (Growth 10y) | 36.07 - 69.72 | 46.50 | 314.8% |
| DCF (EBITDA 5y) | 28.70 - 32.45 | 31.57 | 181.6% |
| DCF (EBITDA 10y) | 37.08 - 43.10 | 41.11 | 266.7% |
| Fair Value | -11.96 - -11.96 | -11.96 | -206.71% |
| P/E | (13.69) - 2.91 | (6.23) | -155.6% |
| EV/EBITDA | 8.59 - 13.95 | 11.65 | 4.0% |
| EPV | 64.20 - 77.01 | 70.61 | 529.8% |
| DDM - Stable | (4.19) - (13.69) | (8.94) | -179.7% |
| DDM - Multi | 14.62 - 37.71 | 21.14 | 88.6% |
| Market Cap (mil) | 367.24 |
| Beta | 0.45 |
| Outstanding shares (mil) | 32.76 |
| Enterprise Value (mil) | 268.11 |
| Market risk premium | 4.60% |
| Cost of Equity | 7.57% |
| Cost of Debt | 5.33% |
| WACC | 6.12% |